Low dose [qnco]
Estradiol [horm, phsu, strd]
Combination [qlco]
Gestodene [phsu, strd]
PREVENT [phsu]
Postmenopausal Bone Loss [dsyn]
Objective [inpr]
Purpose [ftcn]
Study [mnob]
Combinations [mnob]
Estradiol [horm, phsu, strd]
Gestodene [phsu, strd]
Prevention [topp]
Bone Loss [patf]
postmenopausal [tmco]
Women [popg]
Study Design [resa]
Assigned [ftcn]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
mg% [qnco]
17 beta-Estradiol [horm, phsu, strd]
Combined [qlco]
mU/g [qnco]
Gestodene [phsu, strd]
Group 2 [inpr]
25s [bpoc]
mg% [qnco]
Estradiol [horm, phsu, strd]
Combined [qlco]
mU/g [qnco]
Gestodene [phsu, strd]
Group 2 [inpr]
mg% [qnco]
Estradiol [horm, phsu, strd]
Combined [qlco]
mU/g [qnco]
Gestodene [phsu, strd]
Group 1 [inpr]
25s [bpoc]
mg% [qnco]
Estradiol [horm, phsu, strd]
Combined [qlco]
mg% [qnco]
Gestodene [phsu, strd]
Group 1 [inpr]
placebo [topp]
Bone Mineral Density [clna]
Spine [bpoc]
follow [tmco]
SEM [medd]
Group 2 [inpr]
25s [bpoc]
Group 2 [inpr]
>90 [qnco]
Group 1 [inpr]
Group 1 [inpr]
placebo [topp]
Group [idcn]
Bone Mineral Density [clna]
mirrored [mnob]
Markers, Biochemical [qlco]
Bone [bpoc]
Average [qnco]
responses [orga]
urinary [qlco]
C-Terminal [amas]
fragment [ftcn]
Type 1 Collagen [aapp, bacs]
Corrected [qlco]
Creatinine [bacs, orch]
Excretion [phsf]
follow [tmco]
baseline [bodm]
SEM [medd]
Group 2 [inpr]
25s [bpoc]
Group 2 [inpr]
Group 1 [inpr]
25s [bpoc]
Group 1 [inpr]
placebo [topp]
Group [idcn]
Lipid [lipd]
effects [qlco]
Active [ftcn]
Group [idcn]
decreases [qnco]
Low density lipoprotein [aapp, bacs, lipd]
follow [tmco]
SEM [medd]
Group 2 [inpr]
25s [bpoc]
Group 2 [inpr]
Group 1 [inpr]
25s [bpoc]
Group 1 [inpr]
placebo [topp]
Group [idcn]
Estradiol [horm, phsu, strd]
therapy [ftcn]
mg% [qnco]
Estradiol [horm, phsu, strd]
Postmenopausal Bone Loss [dsyn]
